J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017 Acerus Reports Fourth Quarter And Full Year 2016 Financial Results March 7, 2017 FDA Panel Rejects Lipocine's Testosterone Pill January 10, 2018
Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017
